From the massive amounts of useful customer-generated data to the exponential growth in computing power, to cheaper, faster data storage and the development of deep neural networks, artificial intelligence (AI) is getting easier and easier to implement. But how does AI rank in the minds of pharmaceutical executives?
To learn more, check out our thoughts in this article we produced for our friends at PharmaPhorum, and stay tuned for more insights on this increasingly important technology.
Defusing the Ticking Lyme Bomb
In partnership with The Lyme Alliance and Dr. Crystal Barnwell, Intouch has developed the Lyme Bomb Detector, a new AI-powered app to help aid in the recognition and diagnosis of Lyme disease, particularly in people with darker skin.
Why AI Equity Is the Next Step for Transformational Pharma
Artificial intelligence is here to stay, and it has the potential to improve health outcomes when done right. But is the data informing your AI biased? How can you know, and what can you do about it? Intouch’s VP of innovation, Abid Rahman, shares insights and advice.